Yposkesi: Yposkesi joins BioPhorum CGT consortium
Key challenges facing biopharmaceutical manufacturers include ensuring production efficiency while operating in a rapidly evolving regulatory environment
Read full article »
Yposkesi develops gene therapies for the treatment of AAV and lentiviral vector.
Read more